Beijing Health Guard Biotechnology Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 450

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Financing Rounds
  • 10

Beijing Health Guard Biotechnology General Information

Description

Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.

Contact Information

Website
www.bj-klws.com
Formerly Known As
Beijing Kangleweishi Biotechnology Co., Ltd.
Ownership Status
In IPO Registration
Financing Status
Formerly PE-Backed
Corporate Office
  • Units 201 and 202 of Building A2, No. 7, Rongchang East Street
  • Economic and Technological Development Zone, Daxing District
  • Beijing, 100176
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Former Stock Listing
920575
Corporate Office
  • Units 201 and 202 of Building A2, No. 7, Rongchang East Street
  • Economic and Technological Development Zone, Daxing District
  • Beijing, 100176
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beijing Health Guard Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Beijing Health Guard Biotechnology‘s full profile, request access.

Request a free trial

Beijing Health Guard Biotechnology Patents

Beijing Health Guard Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025176145-A1 Nine-valent human papillomavirus vaccine and use thereof Pending 23-Feb-2024
JP-2026509820-A Human papillomavirus vaccine and its use Pending 07-Mar-2023
EP-4678185-A1 Human papillomavirus vaccine and use thereof Pending 07-Mar-2023
WO-2024183665-A1 Human papillomavirus vaccine and use thereof Inactive 07-Mar-2023
JP-2026505637-A Construction and use of plasmid expression vectors based on the tac promoter Pending 15-Feb-2023 C12N15/70
To view Beijing Health Guard Biotechnology’s complete patent history, request access »

Beijing Health Guard Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beijing Health Guard Biotechnology FAQs

  • When was Beijing Health Guard Biotechnology founded?

    Beijing Health Guard Biotechnology was founded in 2008.

  • Where is Beijing Health Guard Biotechnology headquartered?

    Beijing Health Guard Biotechnology is headquartered in Beijing, China.

  • What is the size of Beijing Health Guard Biotechnology?

    Beijing Health Guard Biotechnology has 450 total employees.

  • What industry is Beijing Health Guard Biotechnology in?

    Beijing Health Guard Biotechnology’s primary industry is Drug Discovery.

  • Is Beijing Health Guard Biotechnology a private or public company?

    Beijing Health Guard Biotechnology is a Private company.

  • What is Beijing Health Guard Biotechnology’s current revenue?

    The current revenue for Beijing Health Guard Biotechnology is .

  • How much funding has Beijing Health Guard Biotechnology raised over time?

    Beijing Health Guard Biotechnology has raised $315M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process